HealthXL Dublin 2019
HealthXL Global Gatherings – showcasing innovation by bringing together people with ideas, resources and desire to contribute to the evolution of healthcare. Designed to promote valuable dialogue with peers, to connect small groups of senior executives and international leaders to explore partnerships and build long-lasting relationships.
Clinical trial optimization
How can we optimize clinical processes by combining data, analytics, and technology to help bring new medications to market faster? Who are the front-runners in doing so? Have we seen new molecules, and rising ROI as a result of the optimization?
Digital Therapeutics: What’s next?
We have spoken about DTx several times over the last few years. Now that we accept that DTx has a big role to play in patients’ lives, in pharma life-cycles and in the practice of medicine as we know it, what is next on the horizon? Are we being reimbursed as patients and providers, are we building new franchises as pharma, are we identifying common ground in the form of guidelines for evidence building and regulation as DTx companies?
Ask the Investor
Lifting the lid on investments in Digital Health, who are the investors interested in and what partnerships should we keep an eye on.
Launched in 2014 in Dublin, our mission is to help deliver a new vision for healthcare in the digital age.
Our community comprises of leaders and innovators from healthcare, pharmaceutical and medical device organizations including clinicians, investors, researchers, and entrepreneurs.
We bring together the people, thinking and technology needed to address complex healthcare challenges. Offering industry research and evidence-based insights based on our data platform. Our members are able to directly access the intelligence and expertise needed to capture the digital opportunity. As our engagement with our clients has developed, the more we have begun to focus on broader healthcare innovation – leading to our latest chapter with the beta release of our data intelligence platform in Q4 2018